Product

Subunit recombinant vaccine

Aliases

Subunit recombinant vaccine for the prevention of coronavirus infection

2 clinical trials

3 indications

Indication

Indication

Immunologic Factors

Indication

Respiratory Tract Infections

Clinical trial

A Double-blind, Randomized, Prospective, Placebo-controlled Trial to Assess the Immunogenicity, Safety, and Tolerability of a Coronavirus Vaccine in Healthy Volunteers Aged 18 to 60 Years

Status: Completed, Estimated PCD: 2021-08-30

Clinical trial

Multicentre, Double-blind, Randomized, Prospective, Placebo-controlled Trial to Assess the Immunogenicity, Efficacy and Safety of the Coronavirus Vaccine in Healthy Volunteers Aged 18 Years and Older

Status: Active (not recruiting), Estimated PCD: 2023-10-30